Web Analytics

fundsforNGOs

Grants and Resources for Sustainability

You are here: Home / health / RFAs: Epidemiology and Surveillance of CPO-Related Gram-Negative Infections Grant Program (UK)

RFAs: Epidemiology and Surveillance of CPO-Related Gram-Negative Infections Grant Program (UK)

Deadline: 06-Feb-2026

Pfizer Inc. is offering grants of up to £50,000 per project to support innovative healthcare and medical research initiatives in the United Kingdom. The program targets UK-based institutions and encourages projects that improve patient outcomes, foster collaboration, and advance best practices across medical and allied health fields.

Program Overview

The Pfizer UK Grant Program is designed to fund innovative healthcare and medical research projects that generate meaningful outcomes for patients and the healthcare system. The program prioritizes collaboration, interdisciplinary research, and projects that demonstrate potential for high impact in clinical practice or healthcare delivery.

Funding Details

  • Grant amount: Up to £50,000 per project

  • Total program budget: £100,000

  • Purpose: Advance research, improve patient outcomes, and contribute to best practices in healthcare

  • Eligibility period: Projects must comply with submission and reporting timelines set by Pfizer

Eligibility Criteria

Eligible Applicants

  • Organizations only (no individuals, freelance practitioners, or independent medical practices)

  • Institutions located in the United Kingdom

  • Principal Investigator (PI) must hold an advanced degree relevant to healthcare or research (MD, PhD, PharmD, advanced nursing degree, Physiotherapy, Social Work)

  • The PI must be employed or contracted by the applying institution

  • Multi-institution projects are eligible if all participating institutions have defined roles, and the requesting institution acts as the lead

Legal & Administrative Requirements

  • The requesting organization must be legally able to receive funds directly from Pfizer

  • Applicants are strongly encouraged to verify institutional eligibility before submission

  • Grants awarded to ineligible organizations may be rescinded

Eligible Project Types

  • Healthcare innovation projects with measurable patient or system impact

  • Research initiatives addressing clinical outcomes, healthcare delivery, or public health

  • Collaborative or interdisciplinary projects across departments or institutions

  • Projects demonstrating potential for scalability or adoption in clinical practice

How to Apply

  1. Confirm that your institution can legally receive Pfizer funding

  2. Prepare a proposal including:

    • Project description and objectives

    • Detailed budget and justification

    • Team composition and roles (including PI credentials)

    • Expected outcomes and impact on healthcare practice

  3. Submit the proposal through Pfizer’s online application portal (check website for deadlines)

  4. Ensure all required documentation is complete before submission

Key Considerations

  • Principal Investigator credentials must meet Pfizer’s advanced degree requirements

  • Project must be institution-led, not individual-led

  • Multi-institution collaborations must clearly define roles and responsibilities

  • Emphasize innovation, patient impact, and practical application of research results

FAQ

1. Who can apply?
UK-based organizations, including hospitals, universities, and research institutes. Individuals and independent practices are not eligible.

2. What is the maximum grant amount?
Up to £50,000 per project, with a total program budget of £100,000.

3. Can multiple institutions collaborate?
Yes, if all institutions have defined roles, and the requesting institution leads the project.

4. What qualifications are required for the Principal Investigator?
Advanced degrees in relevant fields: MD, PhD, advanced nursing degree, Pharmacy, Physiotherapy, or Social Work.

5. Can a PI from outside the UK lead a project?
No, the PI and institution must be located in the United Kingdom.

6. What happens if an organization is not eligible to receive funding?
Grants may be rescinded if the organization cannot legally receive funds directly from Pfizer.

7. What types of projects are prioritized?
Projects that demonstrate innovation, collaboration, measurable healthcare impact, and potential for best practice adoption.

Conclusion

The Pfizer UK Healthcare & Medical Research Grant provides an important opportunity for UK-based institutions to advance impactful healthcare projects, foster collaboration, and improve patient outcomes. By supporting innovative initiatives, Pfizer aims to strengthen healthcare research and professional practice across the United Kingdom.

For more information, visit Pfizer.